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Abstract
During brain development, neural stem cells (NSCs) receive on-or-off signals important for regulating their amplification and
reaching adequate neuron density. However, how a coordinated regulation of intracellular pathways and genetic programs
is achieved has remained elusive. Here, we found that the embryonic (e) CSF contains 1012 nanoparticles/ml (77 nm
diameter), some of which were identified as exosome nanovesicles that contain evolutionarily conserved molecules
important for coordinating intracellular pathways. eCSF nanovesicles collected from rodent and human embryos
encapsulate protein and microRNA components of the insulin-like growth factor (IGF) signaling pathway. Supplementation
of eCSF nanovesicles to a mixed culture containing eNSCs activated the IGF-mammalian target of rapamycin complex 1
(mTORC1) pathway in eNSCs and expanded the pool of proliferative eNSCs. These data show that the eCSF serves as a
medium for the distribution of nanovesicles, including exosomes, and the coordinated transfer of evolutionary conserved
molecules that regulate eNSC amplification during corticogenesis.
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Introduction
NSC amplification during development is a critical determinant
of neuron density and thus brain size and function, and alterations
in NSC behavior have a dramatic impact on brain function at any
stage of life [1]. In light of its physiological and pathological
significance, the amplification and self-renewal of NSCs is under
strict regulation by extracellular signals during embryogenesis [2].
Recent studies identified the embryonic cerebrospinal fluid
(eCSF) as a reservoir of signals that directly target NSCs and
regulate their proliferation [3,4]. The eCSF is essentially produced
by the choroid plexus, a highly vascularized plexus of epithelial
cells generated at about embryonic day 12 (e12) in rats and
Carnegie stage 18 in humans [5,6]. One of the signaling molecules
identified in the eCSF is insulin-like growth factor (IGF) 2, which
regulates NSC proliferation through activation of IGF-1 receptors
[3,4]. In addition, an array of intercellular and intracellular
proteins has recently been identified in the human and rat eCSF
[7]. The surprising wealth of intracellular molecules in the eCSF
raises questions regarding their functionality for regulating the
behavior of eNSCs. One intriguing possibility is that eCSF-borne
signaling molecules are packaged in vesicles preventing them from
being degraded and allowing signal transfer to eNSCs lining the
ventricular wall.
Nanovesicles such as exosomes transfer protein, mRNA, and
microRNA between cells and have emerged as a novel mechanism
of intercellular communication [8,9]. Exosomes have been found
in murine eCSF [10] and in the CSF of adult humans [11–14].
Therefore, we tested whether nanovesicles present in the eCSF
during cortical development carried elements of the IGF pathway.
Here, we identified nanovesicles, including exosomes in the
eCSF of both rodents and humans that contain microRNAs and
proteins, the presence of which is evolutionarily conserved
between these lower and higher order mammalian species. In
particular, nanovesicles contain critical components of growth and
proliferation pathways, including IGF-1 receptor pathway and
canonical downstream signaling mediators. Exposing mixed
cultures containing eNSCs to eCSF-extracted nanovesicles led to
activation of the IGF-mTORC1 signaling pathway. Thus,
signaling molecules in eCSF nanovesicles offer a molecular
quantum providing a multi-layer regulation of intracellular
pathways as opposed to an on-or-off regulation provided by
individual eCSF signaling molecules.
Results
Nanovesicles in the eCSF include exosomes and contain
elements of the IGF pathway
To determine whether vesicles are present in the CSF of e14–15
rats during the peak corticogenesis, eCSF in the lateral ventricular
cavity was labeled with a tracer dye and collected with a
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micropipette (Figure 1A and movie S1) as previously described
by others [10,15]. CSF of e14 embryos was subjected to
nanoparticle tracking (NanoSight) analysis to quantify the number
and size of nanoparticles present in the eCSF. We found that the
eCSF contains 1.061012 nanoparticles/ml that were 77.361.8 nm
in diameter (N= 3) consistent with the size of exosomes and other
types of nanovesicles (fractionated released midbodies, ectosomes,
and cilia-released membrane vesicles) [16,17] (Figure 1B and
movie S2). To isolate nanovesicles including exosomes from
eCSF, we used a polymer-based purification strategy following a
previously described protocol [18,19]. The isolated fraction was
visualized by electron microscopy, which showed the presence of
characteristic cup-like nanovesicles resembling exosomes ranging
from 30 to 150 nm in size (Figure 1C) [20]. To further examine
whether the isolated fraction contained exosomes, we assayed for
the presence of several proteins known to be in exosomes [21–25].
By immunoblot we detected the presence of the exosomal marker
proteins CD63 and HSP70 (Figure 1D). We also found PTEN, a
protein consistently found in exosomes and the enzyme PKM2,
previously identified in exosomes [24] (Figure 1D). We confirmed
the absence of PTEN and PKM2 in the polymer-based solution
alone and in the supernatant from the eCSF mixed with the
polymer-based solution (Figure S1A). In addition, we measured
the activity of PKM2, a key enzyme in the glycolytic pathway.
PKM2 enzymatic activity was assessed using a colorimetric assay,
which quantified the amount of pyruvate generated from
phosphoenolpyruvate and demonstrated a time-dependent in-
crease in pyruvate in the exosomal fraction (Figure 1E). We
found that the cytoplasmic protein phospholipase D1, which has
not been found in exosomes [26], was absent from the isolated
fraction containing nanovesicles (e.g, pellets, Figure S1B) ruling
out contamination by cytoplasmic molecules. We also found no
significant trace of blood contamination by measuring heme levels
in the eCSF fraction (0.000107% of the heme level in blood).
Collectively, these data show that nanovesicles including exosomes
are present in the eCSF during corticogenesis as previously
reported [10].
To explore for the presence of key components of the IGF
signaling pathway in nanovesicles, we performed immunoanalysis
(using the phospho (p)-pathscan assay) from e14–15 eCSF-isolated
nanovesicles. We identified IGF pathway components including
phospho (p)-STAT3, pAKT, pERK1/2, pSTAT1, pS6, pmTOR,
and pS6K1 (all significantly increased over control at p.0.05 or
more, Student’s t-test, Figure 1F). Collectively, these results show
that eCSF-isolated nanovesicles contain functionally active meta-
bolic enzymes and key developmental regulators that are part of
the IGF pathway.
Nanovesicles from rat and human eCSF contain IGF
pathway-interfering microRNAs
We next isolated RNA from eCSF nanovesicles (120.8620.3 ng
in ,100–200 ml of CSF per rat litter). We identified the presence
of several RNA species, including microRNAs and non-coding
RNAs. To identify which microRNAs were present in nanove-
sicles, we performed microRNA microarray analysis. Out of 1166
rat probes in the array, 107 and 40 microRNAs had expression
levels 4-fold and 16-fold greater than background levels, respec-
tively (Figure 2A and B, and Table S1). The 16-fold enriched
microRNAs represent 3.4% of the total probed microRNAs. In
comparison a recent study identified 355 microRNAs in the
developing cortex at E13 [24]. The microarray findings were
further validated by confirming the presence of nine of the top
microRNAs [miR-124; 125b; 17-5; 92b; 93; 92a; 181a; 99b, and
Let-7] by quantitative and endpoint RT-PCR (Figure 2C).
Bioinformatics cluster analysis of the identified 16-fold enriched
microRNAs revealed that 9 microRNAs cluster within the IGF
pathway (Figure 2D). Collectively, these data show that eCSF
nanovesicles are enriched with IGF pathway-interfering micro-
RNAs, some of which are known to play critical roles in brain
development.
The identification of nanovesicles in lower order mammalian
species compelled us to ask whether nanovesicles are also present
within the CSF of human embryos. Nanovesicles including
exosomes have indeed been isolated from adult human CSF
[11–14], but not human eCSF. CSF was isolated from post-
conception week 8–12 human embryos. Isolated human eCSF was
prefractionated and subjected to vesicle isolation. Western blots for
CD63, CD81, and HSP70 confirmed the presence of exosomes in
human eCSF (Figure 3A). Pathscan analysis of proteins in the
eCSF nanovesicles showed the presence of components of the IGF
pathway, albeit at different relative levels from those in rats
(Figure 3B). From human eCSF nanovesicles, we prepared
microRNA fractions and subjected samples to array analysis. We
identified 167 microRNAs that were expressed 16-fold greater
than background (Figure 3C, and Table S2).
Microarrays contain probes for humans and rats, which allows
for cross-species comparison of nanovesicle microRNAs. We
found that the most highly enriched human microRNAs were also
present in rats, including miRNA-124, 125b, and 320a/b. In
addition, only 15 microRNAs were significantly differentially
expressed between rats and humans (Figure 3D). 73.3% of
differentially expressed microRNAs had no comparable rat
homologues (11/15). We next performed bioinformatic analysis
of the top 167 microRNAs (16-fold enriched) found in human
eCSF nanovesicles to identify pathway clusters that may be
integral to fetal human development. As in rodents, this analysis
identified the presence of an IGF/Insulin-activated microRNA
node comprised of miR-1913, 423, 155, 130a, and 10 (red on
diagram) as well as miR-324 (pink), which was shared with the rat
IGF/Insulin node (Figure 3E). In addition, all rat IGF/Insulin
node microRNAs (except miR-301a) were present in humans
(black in Figure 3E), albeit at a lower level (4-fold instead of 16-
fold enriched).
eCSF nanovesicles applied to a mixed eNSC-neuroblast
culture activate the IGF-mTORC1 signaling pathway in
NSCs in vitro
Considering that eNSCs are in direct contact with the eCSF, we
explored whether eCSF nanovesicles are capable of activation the
IGF pathway in eNSCs. Cortical NSCs from e12.5 mice were
cultured in a defined media, which is free of eCSF nanovesicles,
for 24 hours as previously reported [27]. The culture contained a
mixed cell population mostly composed of eNSCs and neuroblasts
(doublecortin-positive) and eventually neurons (NeuN-positive)
generated over time (data not shown). Mouse e14 CSF purified
nanovesicles or FBS-free media subjected to nanovesicle isolation
(control) were used to treat eNSCs for 24 hours. Data were
obtained from 3 and 4 cultures and 2-4 litters for nanovesicle
extraction as specified in the figure legend. We then examined the
phosphorylation of the ribosomal protein S6 (serine S240/244),
which is an established readout of IGF-mTORC1 pathway
activity [28]. Treatment of eNSCs with eCSF nanovesicles resulted
in a significant 66% increase in the number of phospho (p) S6-
positive cells (p,0.001, Student’s t-test, Figure 4A-C). The
increase in pS6 was almost completely ablated by rapamycin, a
mTORC1 inhibitor (Figure 4C). eNSC exposure to eCSF
nanovesicles also resulted in a significant 57% increase in the
total number of cells (p,0.05, Figure 4D). However, rapamycin
Content of Embryonic CSF Microvesicles
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did not alter the nanovesicle-induced increase in total cell number,
suggesting that activation of an mTORC1-independent pathway is
responsible for cell number regulation (data not shown). The
change in total cell number was not due to an increase in the
percentage of neurons examined by NeuN immunostaining (data
not shown). Rather, there was a 2-fold increase in the percentage
of eNSCs in culture (from 6% to 12%, p,0.05, Figure 4E) and a
significant increase in the percentage of proliferative (Ki67-
positive) nestin-positive cells (i.e., eNSCs) from 1% to 50%
(p,0.001, Figure 4F). As an additional control, we subjected
cells to nanovesicle-depleted eCSF resulting in only a 15%
increase in the number of proliferative eNSCs (N=3 cultures, data
not shown). To further assess specificity of the effect of eCSF
nanovesicles on eNSCs, we also treated the mixed eNSC cultures
with nanovesicles isolated from cortical e17 neurons cultured for 2
days. Nanovesicles isolated from this neuronal culture had no
effect on the number of proliferative eNSC, but affected neuronal
differentiation (N= 3 cultures, data not shown). These results
demonstrate that eCSF nanovesicles applied to a mixed eNSC-
neuroblast culture activate the PI3K-mTORC1 signaling pathway
downstream of IGF signaling in eNSCs that was accompanied by
alteration in their proliferative behavior independent of
mTORC1.
Discussion
Here, we report that eCSF nanovesicles contain microRNAs
and proteins, the presence of which is evolutionarily conserved
between lower order (rodent) and higher order (human) mamma-
lian species. Intriguingly, the set of proteins and microRNAs
contain critical and functional components of the IGF signaling
pathway that regulate mTORC1 activity in eNSCs. Finally,
exposing eNSCs to eCSF nanovesicles led to NSC amplification
independent of mTORC1. Thus, our work implicates nanovesicles
in the eCSF as critical determinants of eNSC development
Figure 1. Rodent eCSF nanovesicle purification and protein expression. (A) Flow chart of the experimental design after CSF labeling with a
tracer dye (fast green) and eCSF collection. (B) Histogram of size distribution of eCSF nanoparticles (per ml) determined by nanoparticle tracking
analysis (NanoSight). The nanoparticles were obtained from e14 CSF from three rat litters (N = 3). The mean nanoparticle diameter was 77 nm and
was obtained by Gaussian curve fitting. (C) Electron micrographs of rat embryonic purified nanovesicles. Scale bar: 30 nm. (D) Immunoblots for rat
exosomal marker proteins CD63 and HSP70, and additional proteins known to be in exosomes. PTEN and PKM2. (E) Quantification of phosphoenol
pyruvate kinase enzymatic activity determined from rat nanovesicles. (F) Quantification of IGF pathway-related proteins in nanovesicles isolated from
e15 rat CSF using the phospho (p)-pathscan assay. Error bars: SEM. Experiments were reproduced with nanovesicles isolated from three litters (N = 3).
doi:10.1371/journal.pone.0088810.g001
Content of Embryonic CSF Microvesicles
PLOS ONE | www.plosone.org 3 February 2014 | Volume 9 | Issue 2 | e88810
through the transfer of an evolutionary conserved molecular
community providing multiple layers of IGF pathway regulation.
The eCSF has recently been reported to contain an unantic-
ipated large repertoire of molecules, including cytoplasmic and
nuclear proteins [7]. A proteomics-based study further emphasizes
the importance of the eCSF during embryogenesis and highlights
the necessity to have carriers for eCSF intracellular proteins to be
protected from degradation and remain functional [4]. In fact, an
earlier study in e10.5–e12.5 mice reported the presence of particles
of different sizes (,600 nm and 50–80 nm) including exosomes in
the ventricular fluid that were presumably released by neuroep-
ithelial cells based on the expression of CD133 (prominin 1) in
these nanovesicles [10]. Our study further supports the presence of
nanovesicles, including exosomes in the eCSF that are present in
large quantities (trillions/ml). There are no studies using nano-
particle tracking to estimate the quantity of nanovesicles in
embryonic or adult CSF. Nevertheless, the number of vesicles
calculated in blood from patients is 1.0761010 and increases by
four-fold in ovarian cancer patients [29]. In normal rodent eCSF,
we have thus nearly 100 times more nanoparticles than in the
blood of adult humans. We identified nanovesicles as exosomes
based on their size (77 nm diameter) and marker expression such
as CD63. In addition, the isolated eCSF nanovesicles contained
molecules such as PTEN and PKM2 found in exosomes as listed in
the online database ExoCarta.org. The greatest risk of contam-
ination is from the blood since a sharp glass pipette is inserted
through the cortical tissue to reach the lateral ventricle. However,
we used a method described by others that showed no visible
contamination by cells, including red blood cells [7,15]. In
addition, we found that there was no significant trace of heme in
the collected eCSF.
The nanovesicles isolated from eCSF from both rodents and
humans contained a repertoire of proteins and non-coding RNA
of different sizes that include microRNAs. We identified an
overrepresentation of proteins and microRNAs that interfere with
the IGF signaling pathway. This finding is consistent with the
Figure 2. microRNA analysis of rat eCSF nanovesicles. (A) Heat map of microRNA microarrays from eCSF purified nanovesicles. The lighter the
color (yellow) indicates higher expression whereas the darker the color (dark purple) is an indication of absence of expression. Values range from
(log2) 0.64 (bottom) to (log2) 15.4 (top). The top 24 enriched microRNAs are listed on the right. (B) Rank expression of microRNAs based on microarray
expression levels. (C) Quantitative (q) RT-PCR of exosomal RNA using selective exosomal microRNA primers or lacking primers (Neg CTL: negative
control). Bottom: Corresponding end-point RT-PCR. (D) Bioinformatic analysis of microRNA interacting pathways. N= 4 litters of rats.
doi:10.1371/journal.pone.0088810.g002
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critical function of the IGF signaling pathway on eNSC
development and corticogenesis [3,30]. Interestingly, the eCSF
nanovesicles contained molecules that can exert a tight regulation
of the IGF pathway activity by either increasing (e.g., phospho-
AKT) or decreasing its activity (e.g., PTEN). Changes in the
relative level of individual molecules inside the nanovesicles could
influence the outcome of this tug of war exerted on the IGF
pathway. Thus, the molecules in eCSF nanovesicles offer a multi-
layer regulation of intracellular pathways and genetic programs as
opposed to an on-or-off (binary) regulation provided by individual
eCSF signaling molecule.
A surprising result of our study is that the majority of
microRNAs, which were identified in human eCSF nanovesicles
were also detected in rat eCSF nanovesicles. Nevertheless, a small
cohort of microRNAs showed differential expression beyond what
was predicted by significance analysis of microarray (SAM). The
differential expression of these microRNAs could potentially alter
the timing, rates, or types of divisions in eNSCs. For example,
miR-1915 has been reported to be expressed in human eNSCs
where it regulates a pro-neurogenic transcript, Notch-1 [31].
Ultimately, a combination of targets of each microRNA in their
respective species could account for the fine tuning of eNSCs
during cortical development.
Exposing e12.5 NSCs to eCSF nanovesicles led to the activation
of the PI3K-mTORC1 signaling pathway downstream IGF
signaling and impacted the development of eNSCs. In particular,
nanovesicles significantly increased the number of total as well as
proliferative eNSCs in vitro. The effect of nanovesicles on eNSC
proliferation was independent of mTORC1 activity since it
persisted in the presence of rapamycin. This is consistent with a
recent study reporting that mTORC1 activation does not induce
neonatal NSC to proliferate [32]. The lack of rapamycin effect
does not rule out a contribution of nanovesicle IGF signaling on
eNSC proliferation. Indeed, IGF signaling can activate several
pathways including ERK and AKT signaling that could contribute
to the proliferation effect of nanovesicles on eNSC amplification
independent of mTORC1 [33]. Considering that the e12.5 culture
also contained neuroblasts, it is possible that the effect of
nanovesicles on eNSCs was indirect via the release of unknown
factors form e12.5 neuroblasts. Nonetheless, these data suggest
that molecules in the nanovesicles are functional and interfere with
the IGF signaling pathway in embryonic neural cells, possibly
directly in eNSCs.
Our data open a new series of questions that are outside the
scope of this first study. For example, it is conceivable and likely
that the composition of nanovesicles changes over time and thus
differently affects the activity of the IGF signaling pathway and
eNSC development. future work is also require to identify the
sources of eCSF nanovesicles. The choroid plexus is a likely
contributor to nanovesicle synthesis and release [13], but other
sources include the eNSC themselves, neuroblasts, and perhaps
endothelial cells. Developing novel methods to remove endoge-
nous exosomes from the eCSF or change the levels of selective
Figure 3. Analysis of human eCSF nanovesicles. (A) Western blots for CD63, CD81, and HSP70 on purified human eCSF nanovesicles. (B)
Pathscan analysis of human eCSF nanovesicles. All except CC3 are statistically above background at p,0.05. n.s., not significant. (C) Rank expression
of human microRNAs based on microarray expression levels. (D) Differentially expressed microRNAs identified by Significant Analysis of Microarray
(SAM) are indicated and represented in the heat map for human nanovesicles (left) and rat nanovesicles (right). Expression values range from low
(bright green) to intermediate (black) to high (red). (E) Bioinformatic analysis of microRNA interacting pathways identified in eCSF purified human
nanovesicles. Red microRNAs: 16-fold enriched (not shared with rat microRNAs); pink microRNA: 16-fold enriched and shared with rat; black
microRNAs: 4-fold-enriched in humans and 16-fold enriched in rats. N = 4 humans. Error bars: SEM.
doi:10.1371/journal.pone.0088810.g003
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molecules in endogenous exosomes are additional directions to be
pursued.
Collectively, our findings set the stage for future studies aimed at
examining the role of eCSF nanovesicles and more specifically
exosomes on eNSC development as well as the influence of
individual molecules specifically on the IGF signaling pathway in
eNSCs. At the present stage, our data are underscored by the fact
that alterations in the IGF1-PI3K-AKT pathways are observed in
tumors of neural origin and disorders associated with severe
neurological symptoms such as Tuberous sclerosis complex (TSC)
and hemimegalencephaly [34–36]. Defects in the molecular
content of nanovesicles could contribute to non-cell autonomous
mechanisms of disease progression in neurodevelopmental disor-
ders. Therefore, although exosomes have been identified as
candidate biomarkers of schizophrenia and epilepsy, the potential
contribution of nanovesicles and more specifically exosomes to the
origin or amplification of neuropathological development should
be considered.
Materials and Methods
Ethics statement
The human eCSF was obtained from the following Research
tissue Bank: the MRC-Wellcome Trust Human Developmental
Biology Resource (HDBR) at URL: http://www.hdbr.org/. The
eCSF was obtained with approval by the institutional review
boards at the Yale University School of Medicine and University
of Newcastle, from which tissue specimens were obtained. Tissue
Figure 4. Nanovesicles from eCSF increase IGF-mTORC1 activity in eNSCs in vitro. (A) Control and nanovesicle-treated eNSCs in vitro
immunostained for phospho-(p) S6 (red), and nestin (green), and counterstained for the nuclear marker DAPI (blue). (B) Zoom of the image in the
white square in (A). (C) Number of phospho-S6-positive cells relative to total with or without nanovesicle application (N= 3 and 4 cultures, 2–4 litters
for nanovesicle extraction). Experiments were reproduced in the presence of vehicle (DMSO) or 100 nM rapamycin (N= 3 each). (D) Relative total cell
number (N= 3 each). (E) Percentage of nestin-positive eNSCs (N= 3 each). (F) Percentage of Ki67- and nestin-positive eNSCs (N= 9 control and 3 with
nanovesicle). *: p,0.05, **: p,0.01, ***: p,0.001 with Student’s t test or one way ANOVA. Scale bars: 200 mm (A and B). Error bars: SEM.
doi:10.1371/journal.pone.0088810.g004
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was handled in accordance with ethical guidelines and regulations
for the research use of human brain tissue set forth by the NIH
and the University of Newcastle. Donors are asked to give explicit
written consent for the fetal material to be collected. Animal
protocols were approved by the Yale University Institutional
Animal Care and Use Committee.
Animal use
Experiments were performed on timed pregnant CD1 mice or
Sprague Dawley rats from Charles River. Mice and rats were of
either gender. All experiments were reviewed and approved by the
Yale University Institution for Animal Care and Use committee.
Embryonic CSF isolation, tracking analysis, and vesicle
isolation
Pregnant dams (embryonic day 14–18) were injected with
Buprenorphine 30 minutes prior to anesthesia by isoflurane.
Animals were shaved, laparotomy performed, and embryos
individually extracted by making an incision through the uterine
horn. Embryos were transferred on ice and removed from
placental sac. The tracer dye Fast green was dissolved in saline
solution (0.9% w/v, Sigma-Aldrich) and was injected into lateral
ventricles using a pulled glass pipette. eCSF was then aspirated
using manual pressure immediately following injection of fast
green. eCSF was sequentially pooled on ice in a pre-chilled 1.5 ml
reaction tube and immediately centrifuged for 15 minutes at
3,000 g to remove cellular debris and supernatant transferred to a
new tube. The Nanosight LM10 nanoparticle characterization
system (NanoSight, NanoSight Ltd, UK) equipped with a blue
laser (638 nm) illumination was used for real-time characterization
of the number and size of the particles. Mean size and particle
concentration values were calculated by the nanoparticle tracking
software. which allows analysis of video images of the particle
movement under Brownian motion captured by Nanosight LM10
and calculation of the diffusion coefficient, sphere equivalent, and
hydrodynamic radius of particles by using the Strokes-Einstein
equation. Alternatively, isolated eCSF was centrifuged at 3,000 g
and supernatant was then mixed with equal volumes ExoQuick
Exosome Precipitation (Systems Biosciences, Mountain View, CA)
solution and placed on a rotisserie overnight at 4uC. Samples were
subsequently centrifuged at 3,000 g at 4uC for 30 minutes.
Supernatant was removed and cell pellets were used for protein or
RNA analysis or incubated with Neurobasal A to treat cells.
Heme measurements
Heme levels were assessed by a colorimetric assay according to
the manufacturer’s instructions (Cayman Chemical, Ann Arbor,
MI). A standard curve was generated by adding hemoglobin
standards to hemoglobin detector from 0.016 g/dl to 0.400 g/dl.
eCSF aspirates were also added to hemoglobin detector. Solution
was added to 96 well plates, covered, and incubated for 15 minutes
at room temperature. Absorbance was measured at 580 nm using
a standard plate reader. Assuming that hemoglobin levels for rats
is 14 g/dl, samples have a mean of 0.000107% heme compared to
that in the blood.
Electron microscopy
Electron microscopy was performed by the Yale imaging core
facility. Briefly, purified vesicles were resuspended in 4% wt/vol
paraformaldehyde in phosphate buffered solution (pH 7.4) and
embedded for 20 minutes at room temperature in a formvar-
carbon-coated grid. The embedded vesicles were washed in
phosphate buffered saline (PBS), fixed in 1% gluteraldehyde for 5
minutes, and stained with saturated aqueous uranyl oxalate.
Samples were subsequently embedded in 0.4% wt/vol uranyl
acetate and 1.8% wt/vol methylcellulose on ice for 10 minutes.
Samples were dried at room temperature prior to visualization
with a Carl Zeiss 910 electron microscope (Carl Zeiss Microscopy,
Thornwood, NY).
Exosomal RNA and microRNA isolation
To isolate total RNA, Trizol was added to vesicle pellets and
vortexed for 15 seconds. Following a 5 minute-incubation at room
temperature, chloroform was added to each tube. Samples were
subjected to vigorous manual shaking for 15 seconds, incubated
for an additional 5 minutes at room temperature, and centrifuged
for 15 minutes at 12,000 g at 4uC. The upper aqueous phase was
transferred to a fresh tube and isopropyl alcohol added to
precipitate RNA. Samples were incubated for 30 minutes at 4uC
then centrifuged for 10 minutes at 12,000 g at 4uC. Supernatant
was discarded and pellets were washed with 70% ethanol,
vortexed, and centrifuged for 5 minutes at 12,000 g at 4uC. The
previous step was repeated and samples dryed and rehydrated in
RNase/DNase free DEPC treated water. For microRNA isolation,
vesicle pellets were incubated with Lysis buffer for 5 minutes at
room temperature following 15 seconds of vortexing. 100%
ethanol was added to each sample and vortexed for 10 seconds.
Samples were then transferred to a spin column (Systems
Biosciences, Mountain View, CA) and centrifuged for 15 minutes
at 12,000 g at 4uC. Flow through was discarded and wash buffer
was added. Samples were centrifuged at 12,000 g for 1 minute and
samples were washed two more times. Spin columns were placed
into fresh prechilled 1.5 ml elution tubes. Elution buffer was added
directly to membranes of spin columns and centrifuged at 2,000 g
for 2 minutes. Eluate was added back to spin columns and a final 1
minute centrifugation step was performed at 12,000 g at 4uC.
ImmunoBlot and Pathscan
Vesicles were lysed in 100 ml Ripa Buffer and equal amounts 2x
Laemmli buffer. In the case of human fetal samples, protein was
purified following Trizol extraction using a chloroform-methanol
precipitation and processed as above. Equal amounts of vesicles (in
terms of number of particles) were resolved by standard
electrophoresis conditions on 7.5% polyacrylamide precast mini-
Protean TGX gels and transferred to polyvinylidene difluoride
membranes. Membranes were rinsed in TBST (Tris-buffered
saline, 0.1% Tween 20) for 5 minutes at room temperature and
subsequently blocked in 5% w/v nonfat milk in TBST for
18 hours overnight at 4uC. Following three rinses (each of 5
minutes) at room temperature in TBST, samples were incubated
for 1 hour at room temperature or overnight at 4uC with the
following antibodies: PKM2 (Cell Signaling Technology, Danvers,
MA, 1:000), HSP70 (Systems Biosciences, Mountain View, CA,
1:500), CD63 (Systems Biosciences, Mountain View, CA, 1:500),
PTEN (Cell Signaling Technology, Danvers, MA, 1:1000), and
phospholipase D1 (Cell Signaling Technology, Danvers, MA,
1:1000). Following an additional three rinses each of 5 minutes in
TBST, samples were incubated for 1 hour at room temperature
with donkey or goat anti-rabbit antibodies in blocking buffer and
then subjected to four 15-minute washes in TBST and visualized
by enhanced chemiluminescence. In the case of the PathScanH
Intracellular Signaling Array Kits (Fluorescent Readout, Cell
Signaling Technology, Danvers, MA), 1.50 ml RIPA buffer was
used to lyse vesicles. Assembled arrays were incubated in blocking
buffer for 1 hour at room temperature on an orbital shaker. Array
blocking buffer was replaced with 80 ml of vesicle extract and
incubated overnight at 4uC. Lysate was removed and replaced
Content of Embryonic CSF Microvesicles
PLOS ONE | www.plosone.org 7 February 2014 | Volume 9 | Issue 2 | e88810
with array wash buffer four times at room temperature for 5
minutes each time. Arrays were incubated with DyLight 680-
linked to streptavidin for 30 minutes at room temperature on an
orbital shaker, washed for 5 minutes at room temperature four
times with wash buffer and imaged using a LiCor Odyssey
imaging system (Li-Cor Biosciences, Lincoln Nebraska).
Enzymatic assay
A colorimetric pyruvate kinase assay was performed by
measuring pyruvate generation in comparison to pyruvate
standards according to manufacturer’s recommendations (BioVi-
sion Inc., Milpitas, California). Briefly, samples, standards, or
controls were added to Assay buffer. Standard curves were
generated in triplicate with 0.2–10 ng of pyruvate. Diluted
samples were then added to substrate mix, enzyme mix, and
OxiRed Probe. Measurements were performed on 96 well plates
containing samples by determining the optical density (OD) at
565 nm with a microplate reader (Model 550; Bio-Rad, Carlsbad,
CA).
MicroRNA microarrays
Pooled samples from 1–2 litters of purified exosomal RNA or
microRNA were processed by the Yale Center for Genome
Analysis. Approximately 500 ng microRNA was subjected to
labeling and ligation with the FlashTag Biotin Labeling kit
(Affymetrix, Santa Clara, CA) and subjected to ELOSA QC
analysis for ensured labeling. Samples were hybridized to
Affymetrix Genechip miRNA 3.0 arrays (Affymetrix, Santa Clara,
CA) for 16 hours at 45uC, washed, stained with an affymetrix
fluidics station, and scanned using a 16-bit Genechip scanner 3000
(Solid State 532 nm Diode-pumped Frequency Doubled neodym-
ium-doped yttrium aluminum garnet green laser). Samples were
analyzed using the Affymetrix genechip Command Console
software.
Bioinformatic pathway and cross species analysis
MicroRNAs with a greater than 16-fold expression were
subjected to Ingenuity Systems IPA analysis. Pathways with
statistically significant representations were included. Microarray
software suite MultiExperiment Viewer v4 software, which is part
of the TM4 software suite available freely from the J. Craig Venter
Institute (http://www.tm4.org/index.html website) was used for
visualizing and calculating significance analysis of microRNA
microarrays and cross species analysis, and in particular
generating Significance Analysis of Microarrays (SAM) graphs.
qRT-PCR
Approximately 250 ng nanovesicle-purified microRNA was
combined with polyA buffer, 25 mM MnCl2, ATP, and polyA
polymerase along with SeraMir 39 adaptor oligo (Systems
Biosciences, Mountain View, CA) and incubated at 60uC for 5
minutes. Samples were then incubated for 2 minutes at room
temperature and placed on ice. Next, RT master mix, water, a 59
Seramir switch oligo, and reverse transcriptase were combined
with samples and incubated at 42uC for 30 minutes and at 95uC
for 10 minutes to yield cmiDNA. Approximately 25 ng cmiDNA
was combined with IQTM SYBR green supermix, sterile DNase/
RNase free water, a universal 39 Linker targeted primer, and a
sequence specific cmiDNA primer (BioRad Laboratories, USA).
Samples were subjected to 45 rounds of amplification on a BioRad
MyCycler with an initial hot start reaction. MicroRNAs were
detected within 20 cycles and appropriate template amplification
was verified by melt curve analysis along with running out final
products on 2% agarose gels stained with ethidium bromide.
Embryonic NSC and neuronal culture and
immunocytochemistry
Embryonic day 12.5 mouse pups were removed from anesthe-
tized mice following laparotomy and placed into 4uC Neurobasal
A media on petri dishes chilled on wet ice. Dissections were
performed as previously described and demonstrated [27]. Skin
and mesenchymal layers were removed and telencephalic
nanovesicles placed into 0.05% trypsin with 0.02% EDTA and
0.2% BSA in HBSS for 20 minutes in a 37uC incubator. Equal
volumes of 1 mg/ml soybean trypsin inhibitor in HBSS were
added followed by trituration with three pasture pipettes fire-
polished with sequentially decreased bore size to dissociate clumps.
Cells were placed on laminin-coated coverslips in 12 well plates in
complete media (Neurobasal A, Glutamax, and Penicillin/
Streptomycin, Life Technologies, Grand Island, NY). The
following day, complete media was replaced and when indicated,
supplemented with 3336106 nanovesicles/well. We used two
groups of control experiments. For one group of controls, cells
were cultured with FBS-free media subjected to the same vesicle
isolation steps as for the eCSF. For the second group of controls,
cells were subjected to vesicle-depleted eCSF (i.e., the supernatant).
Twenty four hours later cells were fixed by adding equal
volumes of 37uC fixative solution (4% paraformaldehyde in
300 mM sucrose, phosphate buffered saline) directly to the wells.
Half of the solution was then removed from each well and replaced
for a total of four times and incubated at 37uC for 15 minutes.
Coverslips were then washed three times for 5 minutes at room
temperature in wash buffer (PBS, 0.1% Tween-20). Coverslips
were blocked in antibody buffer (PBS, 2% BSA, 0.1% Tween-20)
with 0.1% Triton-X 100 and then washed again three times in
wash buffer for 5 minutes at room temperature. Coverslips were
then incubated in antibody buffer with antibodies against:
phospho-S6 240/244 (Cell Signaling Technology, Danvers, MA,
1:500), Nestin (Novus Partners Inc. NY, 1:500), Ki67 (Vector
Labs, VP-RM04, 1:500), and NeuN (Millipore, MAB377, 1:500).
Coverslips were washed three times for 5 minutes at room
temperature in wash buffer and then incubated in antibody buffer
with the appropriate secondary antibodies (1:1000, Life Technol-
ogies, Grand Island, NY). Following four 15 minute-washes at
room temperature in wash buffer, coverslips were mounted in
ProLongR Gold antifade with DAPI (Life Technologies, Grand
Island, NY) on superfrost microscope slides (Thermo Scientific,
Logan, UT).
Pure cortical e17 neuronal culture were obtained as previously
described [37]. Cells were cultured for two days prior to collecting
the supernatant for vesicle isolation as described above.
Statistical analysis
Statistical analyses for bioinformatics and microarray experi-
ments were performed using MASCOT, Ingenuity, or TM4:
Microarray Software. Student’s t-test or one-way ANOVA was
performed for in vitro experiments.
Supporting Information
Figure S1 (A) Immunoblots for PKM2 and PTEN in rat pellets
(containing eCSF nanovesicles) and in the supernatant from the
eCSF mixed with the Exoquick polymer-based solution, and in the
polymer-based solution alone. This latter data suggest that there is
no cross reactivity between PTEN and PKM2 antibodies and the
extraction polymer. (B) Immunoblots for the non-exosomal
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protein phospholipase D1 in whole cell lysate of Neuro2a cells and
in eCSF pellets containing the nanovesicle fraction.
(TIF)
Table S1 Rat microarray data (excel sheet).
(XLSX)
Table S2 Human microarray data (excel sheet).
(XLSX)
Movie S1 Movie illustrating the isolation of eCSF from e14
embryo still attached to the mother.
(AVI)
Movie S2 Live monitoring of nanoparticles in suspension at
21uC in the NanoSight sample chamber. Total frames: 1195 with
acquired at 19.93 frames per sec. 187 nm/pixel.
(AVI)
Acknowledgments
We thank the Yale proteomic core facility and in particular Dr. Terence
Wu and Dr. Can J. Bruce. The human embryonic and fetal material was
provided by the Joint MRC/Wellcome Trust (grant # 099175/Z/12/Z)
Human Developmental Biology Resource (www.hdbr.org). In addition, we
thank Vibol Heng for his technical assistance. We also thank Dr. Lawrence
Hsieh for providing cultures of e17 cortical neurons.
Author Contributions
Conceived and designed the experiments: DMF AB. Performed the
experiments: DMF SZ CMN SNL. Analyzed the data: DMF SZ CMN.
Contributed reagents/materials/analysis tools: DMF SNL AB. Wrote the
paper: DMF AB.
References
1. Gotz M, Huttner WB (2005) The cell biology of neurogenesis. Nat Rev Mol Cell
Biol 6: 777–788. nrm1739 [pii]; doi:10.1038/nrm1739
2. Okano H, Temple S (2009) Cell types to order: temporal specification of CNS
stem cells. Curr Opin Neurobiol 19: 112–119. S0959-4388(09)00022-1 [pii];
doi:10.1016/j.conb.2009.04.003
3. Lehtinen MK, Zappaterra MW, Chen X, Yang YJ, Hill AD, et al. (2011) The
cerebrospinal fluid provides a proliferative niche for neural progenitor cells.
Neuron 69: 893–905. S0896-6273(11)00071-7 [pii]; doi:10.1016/j.neu-
ron.2011.01.023
4. Lehtinen MK, Walsh CA (2011) Neurogenesis at the brain-cerebrospinal fluid
interface. Annu Rev Cell Dev Biol 27: 653–679. doi:10.1146/annurev-cellbio-
092910-154026
5. Dziegielewska KM, Ek J, Habgood MD, Saunders NR (2001) Development of
the choroid plexus. Microsc Res Tech 52: 5–20. doi:10.1002/1097-
0029(20010101)52:1,5::AID-JEMT3.3.0.CO;2-J
6. O9Rahilly R, Muller F (1994) he Embryonic Human Brain: An Atlas of
Developmental Stages. In: New York: Wiley-Liss.
7. Zappaterra MD, Lisgo SN, Lindsay S, Gygi SP, Walsh CA, et al. (2007) A
comparative proteomic analysis of human and rat embryonic cerebrospinal
fluid. J Proteome Res 6: 3537–3548. doi:10.1021/pr070247w
8. Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, et al. (2007) Exosome-
mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic
exchange between cells. Nat Cell Biol 9: 654–659. ncb1596 [pii]; doi:10.1038/
ncb1596
9. Lee Y, El AS, Wood MJ (2012) Exosomes and microvesicles: extracellular
vesicles for genetic information transfer and gene therapy. Hum Mol Genet 21:
R125–R134. dds317 [pii]; doi:10.1093/hmg/dds317
10. Marzesco AM, Janich P, Wilsch-Brauninger M, Dubreuil V, Langenfeld K, et
al. (2005) Release of extracellular membrane particles carrying the stem cell
marker prominin-1 (CD133) from neural progenitors and other epithelial cells. J
Cell Sci 118: 2849–2858. 118/13/2849 [pii]; doi:10.1242/jcs.02439
11. Street JM, Barran PE, Mackay CL, Weidt S, Balmforth C, et al. (2012)
Identification and proteomic profiling of exosomes in human cerebrospinal fluid.
J Transl Med 10: 5. 1479-5876-10-5 [pii]; doi:10.1186/1479-5876-10-5
12. Huttner HB, Corbeil D, Thirmeyer C, Coras R, Kohrmann M, et al. (2012)
Increased membrane shedding–indicated by an elevation of CD133-enriched
membrane particles–into the CSF in partial epilepsy. Epilepsy Res 99: 101–106.
S0920-1211(11)00338-X [pii]; doi:10.1016/j.eplepsyres.2011.10.029
13. Grapp M, Wrede A, Schweizer M, Huwel S, Galla HJ, et al. (2013) Choroid
plexus transcytosis and exosome shuttling deliver folate into brain parenchyma.
Nat Commun 4: 2123. ncomms3123 [pii]; doi:10.1038/ncomms3123
14. Huttner HB, Janich P, Kohrmann M, Jaszai J, Siebzehnrubl F, et al. (2008) The
stem cell marker prominin-1/CD133 on membrane particles in human
cerebrospinal fluid offers novel approaches for studying central nervous system
disease. Stem Cells 26: 698–705. 2007-0639 [pii]; doi:10.1634/stemcells.2007-
0639
15. Zappaterra MW, LaMantia AS, Walsh CA, Lehtinen MK (2013) Isolation of
cerebrospinal fluid from rodent embryos for use with dissected cerebral cortical
explants. J Vis Exp e50333. doi:10.3791/50333
16. Pan BT, Johnstone RM (1983) Fate of the transferrin receptor during
maturation of sheep reticulocytes in vitro: selective externalization of the
receptor. Cell 33: 967–978. 0092-8674(83)90040-5 [pii].
17. Dubreuil V, Marzesco AM, Corbeil D, Huttner WB, Wilsch-Brauninger M
(2007) Midbody and primary cilium of neural progenitors release extracellular
membrane particles enriched in the stem cell marker prominin-1. J Cell Biol
176: 483–495. jcb.200608137 [pii]; doi:10.1083/jcb.200608137
18. Taylor DD, Zacharias W, Gercel-Taylor C (2011) Exosome isolation for
proteomic analyses and RNA profiling. Methods Mol Biol 728: 235–246.
doi:10.1007/978-1-61779-068-3_15
19. Alvarez ML, Khosroheidari M, Kanchi RR, Distefano JK (2012) Comparison of
protein, microRNA, and mRNA yields using different methods of urinary
exosome isolation for the discovery of kidney disease biomarkers. Kidney Int 82:
1024–1032. ki2012256 [pii]; doi:10.1038/ki.2012.256
20. Chairoungdua A, Smith DL, Pochard P, Hull M, Caplan MJ (2010) Exosome
release of beta-catenin: a novel mechanism that antagonizes Wnt signaling. J
Cell Biol 190: 1079–1091. jcb.201002049 [pii]; doi:10.1083/jcb.201002049
21. Mathew A, Bell A, Johnstone RM (1995) Hsp-70 is closely associated with the
transferrin receptor in exosomes from maturing reticulocytes. Biochem J 308 ( Pt
3): 823–830.
22. Clayton A, Turkes A, Navabi H, Mason MD, Tabi Z (2005) Induction of heat
shock proteins in B-cell exosomes. J Cell Sci 118: 3631–3638. jcs.02494 [pii];
doi:10.1242/jcs.02494
23. Putz U, Howitt J, Lackovic J, Foot N, Kumar S, et al. (2008) Nedd4 family-
interacting protein 1 (Ndfip1) is required for the exosomal secretion of Nedd4
family proteins. J Biol Chem 283: 32621–32627. M804120200 [pii];
doi:10.1074/jbc.M804120200
24. Buschow SI, van Balkom BW, Aalberts M, Heck AJ, Wauben M, et al. (2010)
MHC class II-associated proteins in B-cell exosomes and potential functional
implications for exosome biogenesis. Immunol Cell Biol 88: 851–856. icb201064
[pii]; doi:10.1038/icb.2010.64
25. Putz U, Howitt J, Doan A, Goh CP, Low LH, et al. (2012) The tumor suppressor
PTEN is exported in exosomes and has phosphatase activity in recipient cells.
Sci Signal 5: ra70. 5/243/ra70 [pii]; doi:10.1126/scisignal.2003084
26. Subra C, Grand D, Laulagnier K, Stella A, Lambeau G, et al. (2010) Exosomes
account for vesicle-mediated transcellular transport of activatable phospholipases
and prostaglandins. J Lipid Res 51: 2105–2120. jlr.M003657 [pii]; doi:10.1194/
jlr.M003657
27. Currle DS, Hu JS, Kolski-Andreaco A, Monuki ES (2007) Culture of mouse
neural stem cell precursors. J Vis Exp 152. doi:10.3791/152
28. Aberg MA, Aberg ND, Palmer TD, Alborn AM, Carlsson-Skwirut C, et al.
(2003) IGF-I has a direct proliferative effect in adult hippocampal progenitor
cells. Mol Cell Neurosci 24: 23–40. S1044743103000824 [pii].
29. Gercel-Taylor C, Atay S, Tullis RH, Kesimer M, Taylor DD (2012)
Nanoparticle analysis of circulating cell-derived vesicles in ovarian cancer
patients. Anal Biochem 428: 44–53. S0003-2697(12)00308-9 [pii]; doi:10.1016/
j.ab.2012.06.004
30. Ye P, D9Ercole AJ (2006) Insulin-like growth factor actions during development
of neural stem cells and progenitors in the central nervous system. J Neurosci
Res 83: 1–6. doi:10.1002/jnr.20688
31. Li Y, Mine T, Ioannides CG (2010) Short GC-rich RNA similar to miR 1909
and 1915 folds in silico with the 59-UTR and ORF of Notch and responders:
potential for the elimination of cancer stem cells. Oncol Rep 24: 1443–1453.
32. Hartman NW, Lin TV, Zhang L, Paquelet GE, Feliciano DM, et al. (2013)
mTORC1 Targets the Translational Repressor 4E-BP2, but Not S6 Kinase 1/2,
to Regulate Neural Stem Cell Self-Renewal In Vivo. Cell Rep 5: 433–444.
S2211-1247(13)00540-8 [pii]; doi:10.1016/j.celrep.2013.09.017
33. O9Kusky J, Ye P (2012) Neurodevelopmental effects of insulin-like growth factor
signaling. Front Neuroendocrinol 33: 230–251. S0091-3022(12)00028-3 [pii];
doi:10.1016/j.yfrne.2012.06.002
34. Lee JH, Huynh M, Silhavy JL, Kim S, Dixon-Salazar T, et al. (2012) De novo
somatic mutations in components of the PI3K-AKT3-mTOR pathway cause
hemimegalencephaly. Nat Genet 44: 941–945. ng.2329 [pii]; doi:10.1038/
ng.2329
35. Riviere JB, Mirzaa GM, O9Roak BJ, Beddaoui M, Alcantara D, et al. (2012) De
novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause
a spectrum of related megalencephaly syndromes. Nat Genet 44: 934–940.
ng.2331 [pii]; doi:10.1038/ng.2331
36. Crino PB, Nathanson KL, Henske EP (2006) The tuberous sclerosis complex.
N Engl J Med 355: 1345–1356.
Content of Embryonic CSF Microvesicles
PLOS ONE | www.plosone.org 9 February 2014 | Volume 9 | Issue 2 | e88810
37. Pathania M, Torres-Reveron J, Yan L, Kimura T, Lin TV, et al. (2012) miR-
132 enhances dendritic morphogenesis, spine density, synaptic integration, and
survival of newborn olfactory bulb neurons. PLoS ONE 7: e38174. doi:10.1371/
journal.pone.0038174;PONE-D-12-07179 [pii].
Content of Embryonic CSF Microvesicles
PLOS ONE | www.plosone.org 10 February 2014 | Volume 9 | Issue 2 | e88810
